Molecule Details
InChIKeyFLEVIENZILQUKB-XTWQNQIISA-N
Canonical SMILESCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC[C@H]4CC[C@H](C(=O)OC)CC4)nc32)[C@H](O)[C@@H]1O
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL7.92
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB05009
Drug NameApadenoson
CAS Number250386-15-3
Groups investigational
ATC Codes nan
DescriptionApadenoson is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.

Categories: Acids, Carbocyclic Adenosine A receptor agonists Adenosine A2 Receptor Agonists Cyclohexanes Cycloparaffins Heterocyclic Compounds, Fused-Ring Hydrocarbons, Acyclic Nucleic Acids, Nucleotides, and Nucleosides Nucleosides Purines
Cross-references: BindingDB: 50364063 CHEMBL1950649 ChemSpider: 28490919 PubChem:9805430 PubChem:175426929
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P29274 ADORA2A Homo sapiens Human PF00001 9.3 Ki ChEMBL;BindingDB
P0DMS8 ADORA3 Homo sapiens Human PF00001 7.3 Ki ChEMBL;BindingDB
P30542 ADORA1 Homo sapiens Human PF00001 7.1 Ki ChEMBL;BindingDB
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P29274 ADORA2A Adenosine receptor A2a agonist targets